PLA2G2A and diabetic retinopathy: In an in vivo model of diabetic retinopathy, PLA2 was significantly activated, resulting in the breakdown of the blood–retinal barrier (BRB) caused by the damage to endothelial cells (ECs) and pericytes (PCs), both cellular components of retinal microvessels [70].